Selection Committee

The selection committee process is facilitated by Expedite Animal Health.

The members of the 2014 Selection Committee have a long and distinguished track record in the animal health industry. They bring a mixture of entrepreneurial and established company experience and understand the financial aspects of developing and acquiring technologies.

Anderson, Bill

Bill Anderson

Acting Executive Director, Missouri Technology Corporation

State of Missouri

www.missouritechnology.com


The Missouri Technology Corporation (MTC) is a public-private partnership created by the Missouri General Assembly to promote entrepreneurship and foster the growth of new and emerging high-tech companies. MTC focuses on 21st Century bioscience industries that build on Missouri’s rich history in agriculture.

Baker, Stan

Stan Baker

Patent Attorney, Husch Blackwell, LLP

Kansas City, Missouri

www.huschblackwell.com


Dr. Baker is senior counsel in the Intellectual Property (IP) department of Husch Blackwell, LLP.  He is a registered patent attorney with degrees in chemical engineering and veterinary medicine.  His practice focuses on patents and trademarks, with a particular emphasis in counseling clients with respect to IP portfolio strategy and management, research and business strategy and IP commercialization.  His professional experience includes representing clients in technical matters before the US Patent Office and Federal Courts, serving as general patent counsel for Microban International, Ltd, and private veterinary practice.  Dr. Baker is licensed to practice veterinary medicine in the State of Arkansas.

Boily, Jeff

Jeff Boily

President & CEO, Centaur Animal Health

Olathe, Kansas and Philadelphia, Pennsylvania

Jeff.Boily@centauranimalhealth.com


Jeff is a serial entrepreneur and investor with over 30 years of global life sciences experience. Jeff’s emerging company and fund raising experience includes startups, growth stage and turnaround in pharmaceuticals, biotechnology, drug delivery, medical devices, and clinical informatics. He is a Business Advisor to university investigators seeking early stage funding from the University City Science Center in Philadelphia. He is Chairman of ProteaPex Therapeutics focused on innovative animal health peptide therapeutics. Most recently he was President and CEO of the Center for Animal Health Innovation which focused on funding breakthrough technologies.

Dr. Sam Al-Murrani

Dr. Sam Al-Murrani

Chief Executive Officer, Babylon BioConsulting LLC

babylonbioconsulting.com/


Dr. Al-Murrani has 25 years of life science experience within industry and academia. He has developed and managed operational budgets and high tech equipment purchasing contracts totaling around 25 million dollars. He has extensive business management skills and experience in executive coaching, life sciences investor due diligence, startup funding and the FDA/CVM driven regulatory requirements for multiple industries. He has excellent negotiation skills and has successfully negotiated multi-million dollar research, purchasing and intellectual property licensing contracts, advised on patent applications and provided subject matter expertise.

Dr. Al-Murrani earned his undergraduate degree in animal science from the University of Edinburgh and completed his Ph.D. in immunology/biochemistry at the Roslin Institute and the Department of Veterinary Pathology at the University of Edinburgh.  He holds an M.B.A. from Baker University.

Eagleson, Jane

Jane Eagleson

Owner, Bleecker Street Consulting

New York, New York

jane_eagleson@yahoo.com


Jane is an animal health pharmaceutical industry executive with 25+ years experience working with multinational and small companies in Asia, the USA, Australia and New Zealand.  She is the author of more than 35 publications in peer reviewed journals and has an established track record in global pharmaceutical product development, departmental restructuring/relocation and staff management, Asian R&D unit start up operations, outsourcing and business development.  Her major achievements include development of global pharmaceutical products, including 5 new chemical entities, from Phase I to final regulatory approval and commercialization.  Jane currently works as an independent consultant providing advice and assistance to companies evaluating and developing animal health products for the USA and other markets.

Mannhaupt, John

John Mannhaupt

Vice President, Brakke Consulting, Inc.

Dallas, Texas

www.brakkeconsulting.com


John is experienced in worldwide product introductions, sales management, market research, financial and business planning, and providing business valuations. At Brakke Consulting, John concentrates his activities on business analysis, transactions, and recruiting assignments. His financial background makes him the go-to person for evaluations of businesses and technologies that are either looking for a new owner or seeking to enter the market. He provides a quantitative slant on major strategic decisions. John also specializes in recruiting assignments for positions that are particularly difficult to fill. Previous to joining Brakke Consulting, Mr. Mannhaupt held several sales, product management, and marketing positions with Sandoz Corporation, a major pharmaceutical, chemical, and agricultural products firm that is now part of Novartis.  John also held corporate financial positions with Occidental Petroleum and General Foods, which is now Kraft. He holds an MBA from the Tepper School of Business at Carnegie-Mellon University and a B.S. in Mathematics from Iona College.

Meeusen, Ron

Ronald Meeusen, PhD

Founding Partner, Cultivian Sandbox Food and Ag Funds I & II

Carmel, Indiana

www.sandboxindustries.com/about/cultivian-sandbox


Ron is a founding partner of the Cultivian Sandbox Food and Ag Funds I and II. Ron has over 30 years of experience in bringing new technologies and products to market. He has led research and development for major corporation in agricultural chemicals, field crop and vegetable genetics and breeding, animal health, novel foods and industrial materials. His successful projects include the world’s first field trial of a genetically engineered crop trait in 1986, development and launch of one of the first insect and herbicide resistant corn hybrids in 1996, introduction of a trans-fat free canola oil, and development of dozens of new varieties of field and vegetable crops on three continents. Ron has been a frequent speaker at conferences, a consultant to Federal policy on biotechnology regulatory issues, and active in industry trade groups. Prior to forming Cultivian Ron led the expansion of the biotechnology research and development program of Dow AgroSciences, and founded a successful biopharmaceutical company, Immuneworks, Inc. Ron represents Cultivian on the board of directors of Allylix, Aratana, Proterro and Rivertop Renewables. He was also a member of the board of directors of Divergence, Inc. Divergence was sold to Monsanto Company in February of 2011. Ron holds a Ph.D. from the University of California, Berkeley in plant cell biology, and a bachelor’s degree from the University of Wisconsin, Milwaukee in plant physiology.

Ragland, Chris

Chris Ragland

CEO, Animalytix, LLC

Salisbury, Maryland

www.animalytix.net


Animalytix® LLC is an animal health business intelligence company and the leading provider of geo-located sales information. Animalytix sources its sales data from the leading animal health distributors, veterinarians and retailers and processes more than 20 million sales transactions per year to more than 145,000 veterinarians, retailers and livestock production companies.  The company maintains a comprehensive database of more than $15 billion in sales history on 15,000+ products from more than 500 manufacturers.  Each month, Animalytix publishes a series of syndicated and customized market surveys covering 16 unique animal health market segments and provides additional analytical support through a team of Senior Business Advisors, each former operators from the animal health manufacturing or distribution industries.

Shuler, Rich

Rich Shuler

President & CEO, Shuler Consulting Services

Norcross, Georgia

shulerrich@shulercs.com


Shuler Consulting Services is focused on working with companies in the area of innovation, planning and execution. SCS has more than 30 years of experience in creating and building successful businesses and developing a strong market position for their products and services. Rich Shuler has worked with businesses, producer organizations, churches and universities to develop long range strategic plans and organizational structure. SCS also assists businesses in acquiring products and technologies that fit the company’s strategic focus.

Simpson, Tony

Tony Simpson

Director of Commercialization, Kansas Bioscience Authority

State of Kansas

www.kansasbioauthority.org


The Kansas Bioscience Authority (KBA) was created by the Kansas Economic Growth Act of 2004 with the sole purpose of advancing Kansas’ leadership in bioscience.  The KBA is the state’s largest-ever commitment to expanding Kansas’ research capabilities, promoting innovation, and encouraging company formation that will create high-paying jobs for generations to come.

Warren, Susan

Susan Warren

Branch Manager, Patterson Veterinary

Kansas City, Missouri

www.pattersonvet.com


Susan Warren is a Branch Manager at Patterson Veterinary. Susan works with companies looking to enter the animal health market as well as established multinational animal health companies.  Prior to joining Patterson, Susan operated her own consulting firm advising companies and veterinary practices on business development, new product launches, sales training, and management coaching.  Susan’s 25+ years of industry experience included sales and marketing management positions with IDEXX Laboratories, Quest Diagnostics and Ortho Clinical Diagnostics.